CR Holdings (01911) rose more than 9%, as of the time of publication, rose by 9.66%, to HK$3.18, with a turnover of 3.5389 million Hong Kong dollars.
According to the China Financial APP, CR Holdings (01911) rose more than 9%, rising by 9.66% as of the time of publication, to HK$3.18, with a turnover of 3.5389 million Hong Kong dollars.
On the news front, on November 29, CR Holdings announced the appointment of Wang Lixing, the co-president of the company, as the new chief executive officer, as the former CEO Xie Yijing voluntarily resigned from the position of CEO and executive director due to personal and family reasons. After the appointment, Wang Lixing will continue to serve as an executive director of the company. It is worth noting that since February last year, due to the impact of the founder and former chairman of the board of directors Bao Fan's scandal, there have been frequent changes in the senior management of CR Holdings. The chairman of the board of directors has changed from Xie Yijing to Bao Fan's wife Xu Yanqing, and from Xie Yijing acting as CEO to the current Wang Lixing.
It is reported that Wang Lixing has a seventeen-year career at CR Holdings, starting in July 2007, engaging in investment banking business. Wang Lixing has personally been involved in major market M&A transactions such as the acquisition of Light-in-year, the spin-off financing of Unity China Business, Meituan's acquisition of Mobike, Momo's strategic acquisition of Jianshun, Meituan-Dianping merger, 58 Ganji merger, Didi Kuaidi merger, Tencent's strategic investment in JD.com, Light strategic investment in Maoyan, Dada-JD Daojia merger, Youku Tudou merger, and other well-known market transactions; long-term financing for and assistance to star projects such as Zhipu AI, Baichuan Intelligent, Shengshu Technology, Baidu Kunlun Core, Xiao Du Technology, Zhihu, JD Health, JD Logistics, and more; as well as classic cases of Hong Kong IPOs for well-known projects like Huitongda, Kuaishou, JD Health, etc.